These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27940488)

  • 1. Survival of surgery for recurrent biliary tract cancer: a single-center experience and systematic review of literature.
    Miyazaki Y; Kokudo T; Amikura K; Kageyama Y; Takahashi A; Ohkohchi N; Sakamoto H
    Jpn J Clin Oncol; 2017 Mar; 47(3):206-212. PubMed ID: 27940488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncological outcomes of surgery for recurrent biliary tract cancer: who are the best candidates?
    Sakata J; Nomura T; Aono T; Kitami C; Yokoyama N; Minagawa M; Takizawa K; Miura K; Hirose Y; Ichikawa H; Nagahashi M; Shimada Y; Kobayashi T; Wakai T
    HPB (Oxford); 2021 Sep; 23(9):1371-1382. PubMed ID: 33558069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified Analysis.
    Morino K; Seo S; Yoh T; Fukumitsu K; Ishii T; Taura K; Morita S; Kaido T; Uemoto S
    Ann Surg Oncol; 2020 Jun; 27(6):1908-1917. PubMed ID: 31939034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery for Recurrent Biliary Tract Cancer: A Single-center Experience With 74 Consecutive Resections.
    Takahashi Y; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Nimura Y; Nagino M
    Ann Surg; 2015 Jul; 262(1):121-9. PubMed ID: 25405563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy.
    Ikezawa K; Kanai M; Ajiki T; Tsukamoto T; Toyokawa H; Terajima H; Furuyama H; Nagano H; Ikai I; Kuroda N; Awane M; Ochiai T; Takemura S; Miyamoto A; Kume M; Ogawa M; Takeda Y; Taira K; Ioka T
    J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):98-104. PubMed ID: 23798367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival Benefits of Surgical Resection in Patients with Recurrent Biliary Tract Carcinoma.
    Motoyama H; Kobayashi A; Yokoyama T; Shimizu A; Kitagawa N; Notake T; Fukushima K; Masuo H; Yoshizawa T; Miyagawa SI
    World J Surg; 2017 Nov; 41(11):2817-2829. PubMed ID: 28717913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Site Infection Is Associated with Tumor Recurrence in Patients with Extrahepatic Biliary Malignancies.
    Buettner S; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Weiss M; Fields RC; Krasnick B; Weber SM; Salem A; Martin RCG; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Koerkamp BG; Maithel SK; Pawlik TM
    J Gastrointest Surg; 2017 Nov; 21(11):1813-1820. PubMed ID: 28913712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure to administer multimodality therapy leads to sub-optimal outcomes for patients with node-positive biliary tract cancers in the United States.
    Sheka AC; Altman A; Marmor S; Hui JYC; Denbo JW; Ankeny JS; Jensen EH
    Surg Oncol; 2020 Sep; 34():298-303. PubMed ID: 32891346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of lung recurrence in patients with biliary tract cancer.
    Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Serikawa M; Ishii Y; Arihiro K; Murakami Y; Murashita J; Takahashi S
    Langenbecks Arch Surg; 2023 Jul; 408(1):290. PubMed ID: 37522989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combined prediction model for biliary tract cancer using the prognostic nutritional index and pathological findings: a single-center retrospective study.
    Utsumi M; Kitada K; Tokunaga N; Kato T; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
    BMC Gastroenterol; 2021 Oct; 21(1):375. PubMed ID: 34645392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of initial disease recurrence after resection of biliary tract cancer.
    Jung SJ; Woo SM; Park HK; Lee WJ; Han MA; Han SS; Kim SH; Park SJ; Kim TH; Koh YH; Hong EK
    Oncology; 2012; 83(2):83-90. PubMed ID: 22777276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery for recurrent biliary carcinoma: results for 27 recurrent cases.
    Noji T; Tsuchikawa T; Mizota T; Okamura K; Nakamura T; Tamoto E; Shichinohe T; Hirano S
    World J Surg Oncol; 2015 Feb; 13():82. PubMed ID: 25884694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.
    Utsumi M; Kitada K; Tokunaga N; Yoshida Y; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
    Anticancer Res; 2021 Apr; 41(4):2147-2155. PubMed ID: 33813426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma.
    Kelly KJ; Dukleska K; Kuk D; Kingham TP; D'Angelica MI; DeMatteo RP; Allen PJ; Jarnagin WR; Fong Y
    Ann Surg Oncol; 2014 Mar; 21(3):979-85. PubMed ID: 24212720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer.
    Hong YS; Lee J; Lee SC; Hwang IG; Choi SH; Heo JS; Park JO; Park YS; Lim HY; Kang WK
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):321-8. PubMed ID: 17143602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of repeat surgery for recurrence after primary hepatectomy in patients with intrahepatic cholangiocarcinoma.
    Tokuda K; Morine Y; Saito Y; Yamada S; Miyazaki K; Yamashita S; Okikawa S; Ikemoto T; Imura S; Shimada M
    Int J Clin Oncol; 2020 Dec; 25(12):2083-2089. PubMed ID: 32869120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of repeat hepatic resection for patients with recurrent intrahepatic cholangiocarcinoma: Factors associated with long-term outcomes.
    Si A; Li J; Xing X; Lei Z; Xia Y; Yan Z; Wang K; Shi L; Shen F
    Surgery; 2017 Apr; 161(4):897-908. PubMed ID: 27989605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion surgery for initially unresectable locally advanced biliary tract cancer: A multicenter collaborative study conducted in Japan and Korea.
    Yabushita Y; Park JS; Yoon YS; Ohtsuka M; Kwon W; Choi GH; Imamura M; Matsumoto I; Mizuno S; Matsuyama R; Sakata J; Hayashi H; Takeda Y; Katagiri S; Sugawara T; Kobayashi S; Kawasaki Y; Nagano H; Murase K; Kim HS; Nah YW; Jang JY; Yamaue H; Yoon DS; Yamamoto M; Choi D; Nakamura M; Kim KH; Endo I
    J Hepatobiliary Pancreat Sci; 2024 Jul; 31(7):481-491. PubMed ID: 38822227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.